Publikace

Publikace

seznam publikací: CLIP / spolupráce

2017

Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T.
Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia.
Sci Rep. 2017 Jan 5;7:39710. doi: 10.1038/srep39710. 

Zimmermannova O, Zaliova M, Moorman AV, Al-Shehhi H, Fronkova E, Zemanova Z, Kalina T, Vora A, Stary J, Trka J, Hrusak O, Zuna J.
Acute lymphoblastic leukemia with aleukemic prodrome: preleukemic dynamics and possible mechanisms of immunosurveillance.
Haematologica. 2017 Mar 2. pii: haematol.2016.161380. doi: 10.3324/haematol.2016.161380. 

Kotrova M, van der Velden VH, van Dongen JJ, Formankova R, Sedlacek P, Brüggemann M, Zuna J, Stary J, Trka J, Fronkova E. 
Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL.
Bone Marrow Transplant. 2017 Feb 27. doi: 10.1038/bmt.2017.16. 

Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Schölvinck L, Kalina T, Zachova R, Sediva A, Lambeck A, Pico-Knijnenburg I, van Dongen JJ, Pac M, Bernatowska E, van Hagen M, Driessen G, van der Burg M.
Clin Immunol. 2017 Jan 17;176:77-86. doi: 10.1016/j.clim.2017.01.004.

Křížová L, Kuchař M, Petroková H, Osička R, Hlavničková M, Pelák O, Černý J, Kalina T, Malý P.
Autoimmunity. 2017 Jan 19:1-12. doi: 10.1080/08916934.2016.1272598

Dworzak MN, Buldini B, Gaipa G, Ratei R, Hrusak O, Luria D, Rosenthal E, Bourquin JP, Sartor M, Schumich A, Karawajew L, Mejstrikova E, Maglia O, Mann G, Ludwig WD, Biondi A, Schrappe M, Basso G; International-BFM-FLOW-network.
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
Cytometry B Clin Cytom. 2017 Feb 10. doi: 10.1002/cyto.b.21518.

Zjablovskaja P, Kardosova M, Danek P, Angelisova P, Benoukraf T, Wurm AA, Kalina T, Sian S, Balastik M, Delwel R, Brdicka T, Tenen DG, Behre G, Fiore F, Malissen B, Horejsi V, Alberich-Jorda M.
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Cell Death Differ. 2017 Feb 10.doi: 10.1038/cdd.2017.6.
 
Sediva H, Dusatkova P, Kanderova V, Obermannova B, Kayserova J, Sramkova L, Zemkova D, Elblova L, Svaton M, Zachova R, Kolouskova S, Fronkova E, Sumnik Z, Sediva A, Lebl J, Pruhova S.
Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
Horm Res Paediatr. 2017 Mar 2. doi: 10.1159/000456544.

2016

Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, Heatley SL, Loh ML, Konopleva M, Chen IM, Zimmermannova O, Schwab C, Smith O, Mozziconacci MJ, Chabannon C, Kim M, Frederik Falkenburg JH, Norton A, Marshall K, Haas OA, Starkova J, Stuchly J, Hunger SP, White D, Mullighan CG, Willman CL, Stary J, Trka J, Zuna J.
Characterization of leukemias with ETV6-ABL1 fusion.
Haematologica. 2016 Sep;101(9):1082-93. doi: 10.3324/haematol.2016.144345. Epub 2016 May 26
 
Kotrova M, Musilova A, Stuchly J, Fiser K, Starkova J, Mejstrikova E, Stary J, Zuna J, Hrusak O, Trka J, Zaliova M. 
Blood. 2016 Sep 13. pii: blood-2016-07-725861.
 
Zaliova M, Hovorkova L, Vaskova M, Hrusak O, Stary J, Zuna J
Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16. 

Genes Chromosomes Cancer. 2016 Sep;55(9):727-37. doi: 10.1002/gcc.22374

 
Potuckova E, Zuna J, Hovorkova L, Starkova J, Stary J, Trka J, Zaliova M.
PLoS One. 2016 Aug 5;11(8):e0160385. doi: 10.1371/journal.pone.0160385. eCollection 2016.

Pelák O, Kužílková D, Thürner D, Kiene ML, Stanar K, Stuchlý J, Vášková M, Starý J, Hrušák O, Stadler H, Kalina T.
Cytometry A. 2016 Aug 4. doi: 10.1002/cyto.a.22918. [Epub ahead of print]

Klener P, Fronkova E, Berkova A, Jaksa R, Lhotska H, Forsterova K, Soukup J, Kulvait V, Vargova J, Fiser K, Prukova D, Alam M, Calvin Lenyeletse Maswabi B, Michalova K, Zemanova Z, Jancuskova T, Pekova S, Trneny M.
Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30263. [Epub ahead of print]
 

Zuna J, Moericke A, Arens M, Koehler R, Panzer-Grümayer R, Bartram CR, Fischer S, Fronkova E, Zaliova M, Schrauder A, Stanulla M, Zimmermann M, Trka J, Stary J, Attarbaschi A, Mann G, Schrappe M, Cario G.
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia. 
Br J Haematol. 2016 Feb 23. doi: 10.1111/bjh.13989.

 

Michaela Novakova, Marketa Zaliova, Martina Sukova, Marcin Wlodarski, Ales Janda, Eva Fronkova, Vit Campr, Katerina Lejhancova, Ondrej Zapletal, DagmarPospisilova, Zdenka Cerna,Tomas Kuhn, Peter Svec, Vendula Pelkova, Zuzana Zemanova, Gitte Kerndrup, Marry van den Heuvel-ibrink, Vincent vanderVelden, Charlotte Niemeyer, Tomas Kalina, Jan Trka, Jan Stary,  Ondrej Hrusak, Ester Mejstrikova. 
Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. 

Boublikova L, Bakardjieva-Mihaylova V, Skvarova Kramarzova K, Kuzilkova D, Dobiasova A, Fiser K, Stuchly J, Kotrova M, Buchler T, Dusek P, Grega M, Rosova B, Vernerova Z, Klezl P, Pesl M, Zachoval R, Krolupper M, Kubecova M, Stahalova V, Abrahamova J, Babjuk M, Kodet R, Trka J.
Cancer Lett. 2016 Jul 1;376(2):367-76. doi: 10.1016/j.canlet.2016.04.016. Epub 2016 Apr 13.


Kanderova V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, Hrusak O, Lund-Johansen F, Kalina T.
Mol Cell Proteomics. 2016 Jan 19. pii: mcp.M115.054593. [Epub ahead of print]

 

Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, Sobral da Costa E, Kotrova M, Novakova M, Sonneveld E, Buracchi C, Bonaccorso P, Oliviera E, Te Marvelde JG, Szczepanski T, Lhermitte L, Hrusak O, Lecrevisse Q, Grigore GE, Fronkova E, Trka J, Brüggemann M, Orfao A, van Dongen JJ, van der Velden VH.
Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.
Blood. 2016 Nov 30. pii: blood-2016-07-726307. 

 
 
de Rooij JD, van den Heuvel-Eibrink MM, van de Rijdt NK, Verboon LJ, de Haas V, Trka J, Baruchel A, Reinhardt D, Pieters R, Fornerod M, Zwaan CM.
PHF6 mutations in paediatric acute myeloid leukaemia.

Br J Haematol. 2016 Dec;175(5):967-971. doi: 10.1111/bjh.13891.


Pytlík R, Rentsch C, Soukup T, Novotný L, Rentsch B, Kanderová V, Rychtrmocová H, Kalmárová M, Stehlík D, Trněný M, Slanař O.

Physiol Res. 2016 Oct 26. 

 

Verboon LJ, Obulkasim A, de Rooij JD, Katsman-Kuipers JE, Sonneveld E, Baruchel A, Trka J, Reinhardt D, Pieters R, Cloos J, Kaspers GJ, Klusmann JH, Zwaan CM, Fornerod M, van den Heuvel-Eibrink MM.

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.
Oncotarget. 2016 Jun 24. doi: 10.18632/oncotarget.10270

 

Lund-Johansen F, de la Rosa Carrillo D, Mehta A, Sikorski K, Inngjerdingen M, Kalina T, Røysland K, Antonio de Souza G, Bradbury AR, Lecrevisse Q, Stuchly J.
Nat Methods. 2016 Aug 29. doi: 10.1038/nmeth.3967

de Rooij JD, Masetti R, van den Heuvel-Eibrink MM, Cayuela JM, Trka J, Reinhardt D, Rasche M, Sonneveld E, Alonzo TA, Fornerod M, Zimmermann M, Pigazzi M, Pieters R, Meshinchi S, Zwaan CM, Locatelli F.
Recurrent genetic abnormalities can be used for risk-group stratification in pediatric AMKL: results of a retrospective intergroup study.
Blood. 2016 Apr 25. pii: blood-2016-01-695551
 
 

2015

Pelák O, Stuchlý J, Król L, Hubáček P, Keslová P, Sedláček P, Formánková R, Starý J, Hrušák O, Kalina T.
Cytometry B Clin Cytom. 2015 Dec 8. doi: 10.1002/cyto.b.21348. [Epub ahead of print]
 

Polgárová K, Vášková M, Froňková E, Slámová L, Kalina T, Mejstříková E, Dobiášová A, Hrušák O.
Differentiation. 2015 Dec 7. pii: S0301-4681(15)00072-9. doi: 10.1016/j.diff.2015.11.003. [Epub ahead of print]

Kotrova M, Muzikova K, Mejstrikova E, Novakova M, Bakardjieva-Mihaylova V, Fiser K, Stuchly J, Giraud M, Salson M, Pott C, Brüggemann M, Füllgrabe M, Stary J, Trka J, Fronkova E.
Blood. 2015 Aug 20;126(8):1045-7. doi: 10.1182/blood-2015-07-655159.

Heřmanová I, Arruabarrena-Aristorena A, Vališ K, Nůsková H, Jorda MA, Fišer K, Fernández-Ruiz S, Kavan D, Pecinová A, Niso-Santano M, Žaliová M, Novák P, Houštěk J, Mráček T, Kroemer G, Carracedo A, Trka J, Starková J.
Leukemia. 2015 Aug 4. doi: 10.1038/leu.2015.213. [Epub ahead of print]
 
Fišer K, Slámová L, Bourquin JP, Trka J, Starý J, Hrušák O, Mejstříková E.
Proc Natl Acad Sci U S A. 2015 Jun 11. pii: 201508680. [Epub ahead of print]
 
Dytrych P., Krol P., Kotrova M., Kuzilkova D., Hubacek P., Krol L., Katra R., Hrusak O, Kabelka Z., Dolezalova P., Kalina T., Fronkova E.
Mol Immunol. 2015 May;65(1):139-47. doi: 10.1016/j.molimm.2015.01.004.

Svojgr K, Sumerauer D, Puchmajerova A, Vicha A, Hrusak O, Michalova K, Malis J, Smisek P, Kyncl M, Novotna D, Machackova E, Jencik J, Pycha K, Vaculik M, Kodet R, Stary J.
Eur J Med Genet. 2015 Dec 2. pii: S1769-7212(15)30051-3. doi: 10.1016/j.ejmg.2015.11.013. [Epub ahead of print]

Liskova P, Evans CJ, Davidson AE, Zaliova M, Dudakova L, Trkova M, Stranecky V, Carnt N, Plagnol V, Vincent AL, Tuft SJ, Hardcastle AJ.
Eur J Hum Genet. 2015 Oct 28. doi: 10.1038/ejhg.2015.232. [Epub ahead of print]
 

Szotkowski T, Jarošová M, Zimmermannová O, Meyer C, Marschalek R, Zuna J, Hubáček J, Indrák K.
Cancer Genet. 2015 Dec;208(12):610-4. doi: 10.1016/j.cancergen.2015.09.004. Epub 2015 Sep 15.

Avigad S, Verly IR, Lebel A, Kordi O, Shichrur K, Ohali A, Hameiri-Grossman M, Kaspers GJ, Cloos J, Fronkova E, Trka J, Luria D, Kodman Y, Mirsky H, Gaash D, Jeison M, Avrahami G, Elitzur S, Gilad G, Stark B, Yaniv I.
Genes Chromosomes Cancer. 2015 Dec 19. doi: 10.1002/gcc.22334.

Klocperk A, Mejstříková E, Kayserová J, Kalina T, Šedivá A.
Clin Immunol. 2015 Sep 2;161(2):144-149. doi: 10.1016/j.clim.2015.08.013.
 
Linhartova J, Hovorkova L, Soverini S, Benesova A, Jaruskova M, Klamova H, Zuna J, Machova Polakova K.
Mol Cancer. 2015 Apr 18;14:89. doi: 10.1186/s12943-015-0363-8.

Vlkova M, Ticha O, Nechvatalova J, Kalina T, Litzman J, Mauri C, Blair PA.
Clin Immunol. 2015 Jul 29;160(2):292-300. doi: 10.1016/j.clim.2015.06.013. [Epub ahead of print] 

Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ, Bornhauser B, Gombert M, Kratsch C, Stütz AM, Sultan M, Tchinda J, Worth CL, Amstislavskiy V, Badarinarayan N, Baruchel A, Bartram T, Basso G, Canpolat C, Cario G, Cavé H, Dakaj D, Delorenzi M, Dobay MP, Eckert C, Ellinghaus E, Eugster S, Frismantas V, Ginzel S, Haas OA, Heidenreich O, Hemmrich-Stanisak G, Hezaveh K, Höll JI, Hornhardt S, Husemann P, Kachroo P, Kratz CP, Kronnie GT, Marovca B, Niggli F, McHardy AC, Moorman AV, Panzer-Grümayer R, Petersen BS, Raeder B, Ralser M, Rosenstiel P, Schäfer D, Schrappe M, Schreiber S, Schütte M, Stade B, Thiele R, Weid NV, Vora A, Zaliova M, Zhang L, Zichner T, Zimmermann M, Lehrach H, Borkhardt A, Bourquin JP, Franke A, Korbel JO, Stanulla M, Yaspo ML.
Nat Genet. 2015 Jul 27. doi: 10.1038/ng.3362. [Epub ahead of print]
 
Boer JM, van der Veer A, Rizopoulos D, Fiocco M, Sonneveld E, de Groot-Kruseman HA, Kuiper RP, Hoogerbrugge P, Horstmann M, Zaliova M, Palmi C, Trka J, Fronkova E, Emerenciano M, do Socorro Pombo-de-Oliveira M, Mlynarski W, Szczepanski T, Nebral K, Attarbaschi A, Venn N, Sutton R, Schwab CJ, Enshaei A, Vora A, Stanulla M, Schrappe M, Cazzaniga G, Conter V, Zimmermann M, Moorman AV, Pieters R, den Boer ML.
Leukemia. 2015 Jul 23. doi: 10.1038/leu.2015.199. [Epub ahead of print]

Svobodova T, Mejstrikova E, Salzer U, Sukova M, Hubacek P, Matej R, Vasakova M, Hornofova L, Dvorakova M, Fronkova E, Votava F, Freiberger T, Pohunek P, Stary J, Janda A.
BMC Pulm Med. 2015 Feb 10;15:8. doi: 10.1186/s12890-015-0006-2.

Bugarin C, Sarno J, Palmi C, Savino AM, Te Kronnie G, Dworzak M, Shumich A, Buldini B, Maglia O, Sala S, Bronzini I, Bourquin JP, Mejstrikova E, Hrusak O, Luria D, Basso G, Izraeli S, Biondi A, Cazzaniga G, Gaipa G; I-BFM study group.
Haematologica. 2015 Jun;100(6):e229-32. doi: 10.3324/haematol.2014.114447. Epub 2015 Apr 10.

Felgentreff K, Lee YN, Frugoni F, Du L, van der Burg M, Giliani S, Tezcan I, Reisli I, Mejstrikova E, Villartay JP, Sleckman BP, Manis J, Notarangelo LD.
J Allergy Clin Immunol. 2015 Apr 25. pii: S0091-6749(15)00345-0. doi: 10.1016/j.jaci.2015.03.005.

Zdráhalová K, Štěrba J, Domanský J, Blažek B, Ptoszková H, Mihál V, Novák Z, Hak J, Procházková D, Černá Z, Timr P, Jabali Y, Sedláček P, Smíšek P, Zemanová Z, Jarošová M, Houdková A, Mejstříková E, Hrušák O, Zuna J, Janotová I, Trka J, Starý J.
Cas Lek Cesk. 2015;154(2):79-89. Czech.

Basak A, Hancarova M, Ulirsch JC, Balci TB, Trkova M, Pelisek M, Vlckova M, Muzikova K, Cermak J, Trka J, Dyment DA, Orkin SH, Daly MJ, Sedlacek Z, Sankaran VG.
J Clin Invest. 2015 Jun 1;125(6):2363-8. doi: 10.1172/JCI81163. Epub 2015 May 4.

Šálek C, Folber F, Froňková E, Procházka B, Marinov I, Cetkovský P, Mayer J, Doubek M.
Eur J Haematol. 2015 May 21. doi: 10.1111/ejh.12587. [Epub ahead of print]
 
Karawajew L, Dworzak M, Ratei R, Rhein P, Gaipa G, Buldini B, Basso G, Hrusak O, Ludwig WD, Henze G, Seeger K, von Stackelberg A, Mejstrikova E, Eckert C.
Haematologica. 2015 May 22. pii: haematol.2014.116707. [Epub ahead of print]

de Rooij JD, Beuling E, van den Heuvel-Eibrink MM, Obulkasim A, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Gibson BE, Pieters R, Zimmermann M, Zwaan CM, Fornerod M.
Haematologica. 2015 Jun 11. pii: haematol.2015.124321. [Epub ahead of print]. 2015 Mar 17. doi:10.1038/leu.2015.78
 
Sikora J, Majer F, Kalina T.
J Cardiol. 2015 Jan 27. pii: S0914-5087(15)00006-4. doi: 10.1016/j.jjcc.2014.12.014. [Epub ahead of print] 
 
 

2014

Kalina T, Flores-Montero J, Lecrevisse Q, Pedreira CE, van der Velden VH, Novakova M, Mejstrikova E, Hrusak O, Böttcher S, Karsch D, Sędek L, Trinquand A, Boeckx N, Caetano J, Asnafi V, Lucio P, Lima M, Helena Santos A, Bonaccorso P, van der Sluijs-Gelling AJ, Langerak AW, Martin-Ayuso M, Szczepański T, van Dongen JJ, Orfao A.
Quality assessment program for EuroFlow protocols: Summary results of four-year (2010-2013) quality assurance rounds.
Cytometry A. 2014 Oct 23. doi: 10.1002/cyto.a.22581. 

 

Hrušák OBasso GRatei RGaipa GLuria DMejstříková EKarawajew LBuldini BRozenthal EBourquin JPKalina TSartor MDworzak MNAIEOP-BFM Flow Network.

Flow diagnostics essential code: a simple and brief format for the summary of leukemia phenotyping.

Cytometry B Clin Cytom. 2014 Jul;86(4):288-91.

 

Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, Gonzalez A, Izraeli S, Janic D, Jazbec J, Konja J, Kaiserova E, Kowalczyk J, Kovacs G, Li CK, Magyarosy E, Popa A, Stark B, Jabali Y, Trka J, Hrusak O, Riehm H, Masera G, Schrappe M.
J Clin Oncol. 2014 Jan 20;32(3):174-84. doi: 10.1200/JCO.2013.48.6522. Epub 2013 Dec 16.

Kováč M, Vášková M, Petráčková D, Pelková V, Mejstříková E, Kalina T, Zaliová M, Weiser J, Starý J, Hrušák O.
Eur Cytokine Netw. 2014 Mar 1;25(1):8-13. doi: 10.1684/ecn.2014.0348.
 
Froňková E, Klocperk A, Svatoň M, Nováková M, Kotrová M, Kayserová J, Kalina T, Keslová P, Votava F, Vinohradská H, Freiberger T, Mejstříková E, Trka J, Sedivá A.
The TREC/KREC Assay for the Diagnosis and Monitoring of Patients with DiGeorge Syndrome.
PLoS One. 2014 Dec 8;9(12):e114514. doi: 10.1371/journal.pone.0114514. eCollection 2014.

Kramarzova K, Fiser K, Mejstrikova E, Rejlova K, Zaliova M, Fornerod M, Drabkin HA, van den Heuvel-Eibrink MM, Stary J, Trka J, Starkova J.
J Hematol Oncol. 2014 Dec 24;7(1):1. [Epub ahead of print] 
 

Kalinova M, Fronkova E, Klener P, Forsterova K, Lokvenc M, Mejstrikova E, Belada D, Mocikova H, Trneny M, Kodet R, Trka J.
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma.
Br J Haematol. 2014 Oct 14. doi: 10.1111/bjh.13182.


Hoffmann J, Shmeleva E, Boag SE, Fiser K, Bagnall A, Murali S, Dimmick I, Pircher H, Martin-Ruiz C, Egred M, Keavney B, von Zglinicki T, Das R, Todryk S, Spyridopoulos I.
Circ Res. 2014 Nov 10. pii: CIRCRESAHA.114.304393. [Epub ahead of print]

Klocperk A, Grecová J, Šišmová K, Kayserová J, Froňková E, Šedivá A.
J Clin Immunol. 2014 Oct;34(7):864-70. doi: 10.1007/s10875-014-0071-y. Epub 2014 Jul 10.
 
Lizcova L, Zemanova Z, Lhotska H, Zuna J, Hovorkova L, Mejstrikova E, Malinova E, Rabasova J, Raska I, Sramkova L, Stary J, Michalova K.
Mol Cytogenet. 2014 Oct 24;7(1):72. doi: 10.1186/s13039-014-0072-9. eCollection 2014.
 
Fucikova J, Moserova I, Truxova I, Hermanova I, Vancurova I, Partlova S, Fialova A, Sojka L, Cartron PF, Houska M, Rob L, Bartunkova J, Spisek R.
Int J Cancer. 2014 Feb 5. doi: 10.1002/ijc.28766.
 
Papaemmanuil E, Rapado I, Li Y, Potter NE, Wedge DC, Tubio J, Alexandrov LB, Van Loo P, Cooke SL, Marshall J, Martincorena I, Hinton J, Gundem G, van Delft FW, Nik-Zainal S, Jones DR, Ramakrishna M, Titley I, Stebbings L, Leroy C, Menzies A, Gamble J, Robinson B, Mudie L, Raine K, O'Meara S, Teague JW, Butler AP, Cazzaniga G, Biondi A, Zuna J, Kempski H, Muschen M, Ford AM, Stratton MR, Greaves M, Campbell PJ.
RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.
Nat Genet. 2014 Feb;46(2):116-25. doi: 10.1038/ng.2874. Epub 2014 Jan 12.

Ijspeert H, Driessen GJ, Moorhouse MJ, Hartwig NG, Wolska-Kusnierz B, Kalwak K, Pituch-Noworolska A, Kondratenko I, van Montfrans JM, Mejstrikova E, Lankester AC, Langerak AW, van Gent DC, Stubbs AP, van Dongen JJ, van der Burg M.
Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
J Allergy Clin Immunol. 2014 Jan 10. pii: S0091-6749(13)01848-4. doi: 10.1016/j.jaci.2013.11.028.

Yang JJ, Park TS, Lee ST, Seo JY, Oh SH, Cho EH, Strehl S, Mühlegger N, Dworzak MN, Zuna J, Pospisilova D, Meyer C, Marschalek R, Kim HJ, Kim SH.
Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement.
Haematologica. 2014 Jan;99(1):e11-3. doi: 10.3324/haematol.2013.095638.

 

2013

Ondřej Hrušák, Giuseppe Basso, Richard Ratei, Giuseppe Gaipa, Drorit Luria, Ester Mejstříková, Leonid Karawajew, Barbara Buldini, Eti Rozenthal, Jean Pierre Bourquin, Tomáš Kalina, Mary Sartor and Michael N. Dworzak, on behalf of the AIEOP-BFM Flow Network 
Flow diagnostics essential (FDE) code: A simple and brief format for the summary of leukemia phenotyping
Cytometry B 2013 doi: 10.1002/cytob.21144 

Jan Stuchly, Tomas Kalina 
Analyses of Large Flow Cytometry Datasets
Cytometry A 2013 doi: 10.1002/cyto.a.22431

Slamova L, Starkova J, Fronkova E, Zaliova MK, Reznickova LR, van Delft FW, Vodickova E, Volejnikova J, Zemanova Z, Polgarova K, Cario G, Figueroa M, Kalina T, Fiser K, Bourquin JP, Bornhauser B, Dworzak M, Zuna J, Trka J, Stary J, Hrusak O, Mejstrikova E. 

Boublikova L, Buchler T, Stary J, Abrahamova J, Trka J.
Crit Rev Oncol Hematol. 2013

Zaliova M, Zimmermanova O, Dörge P, Eckert C, Möricke A, Zimmermann M, Stuchly J, Teigler-Schlegel A, Meissner B, Koehler R, Bartram CR, Karawajew L,Rhein P, Zuna J, Schrappe M, Cario G, Stanulla M.
Leukemia. 2013 Sep 27

Froňková E.
Cesk Patol. 2013 Jun


 
 
van der Veer A, Zaliova M, Mottadelli F, De Lorenzo P, Te Kronnie G, Harrison CJ, Cavé H, Trka J, Saha V, Schrappe M, Pieters R, Biondi A, Valsecchi MG, Stanulla M, den Boer ML, Cazzaniga G.
Blood. 2013 Dec 23.

 
Milan Kuchař, Lucie Vaňková, Hana Petroková, Jiří Černý, Radim Osička, Ondřej Pelák, Hana Šípová, Bohdan Schneider, Jiří Homola, Peter Šebo, Tomáš Kalina and Petr Malý 
Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells
Proteins: Structure, Function, and Bioinformatics 2013 doi: 10.1002/prot.24472 
 

Meissner B, Bartram T, Eckert C, Trka J, Panzer-Grümayer R, Hermanova I, Ellinghaus E, Franke A, Möricke A, Schrauder A, Teigler-Schlegel A, Dörge P, von Stackelberg A, Basso G, Bartram CR, Kirschner-Schwabe R, Bornhäuser B, Bourquin JP, Cazzaniga G, Hauer J, Attarbaschi A, Izraeli S, Zaliova M, Cario G, Zimmermann M, Avigad S, Sokalska-Duhme M, Metzler M, Schrappe M, Koehler R, Kronnie GT, Stanulla M. 
Hum Mol Genet. 2013 Sep 17.

Cheng SH, Lau KM, Li CK, Chan NP, Ip RK, Cheng CK, Lee V, Shing MM, Leung AW, Ha SY, Cheuk DK, Lee AC, Li CH, Luk CW, Ling SC, Hrusak O, Mejstrikova E, Leung Y, Ng MH.
PLoS One. 2013 Jul 25

Rensing-Ehl A, Janda A, Lorenz MR, Gladstone BP, Fuchs I, Abinun M, Albert M, Butler K, Cant AJ, Cseh AM, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Kühnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dückers G, Owens S, Roesler J, Schilling FH, Schuster V, Seidel MG, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C.
Haematologica. 2013 Jul 19

Majer F, Pelak O, Kalina T, Vlaskova H, Dvorakova L, Honzik T, Palecek T, Kuchynka P, Masek M, Zeman J, Elleder M, Sikora J.

Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics.

J Inherit Metab Dis. 2013 May 29


Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VH, van Dongen JJ, Delabesse E, Binato R, Silva ML, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WW, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, Zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R.

The MLL recombinome of acute leukemias in 2013.

Leukemia. 2013 Apr 30.


Mirkowska P, Hofmann A, Sedek L, Slamova L, Mejstrikova E, Szczepanski T, Schmitz M, Cario G, Stanulla M, Schrappe M, van der Velden VH, Bornhauser BC, Wollscheid B, Bourquin JP.

Leukemia surfaceome analysis reveals new disease-associated features.

Blood. 2013 May 6


de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Beverloo HB, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, Alonzo TA, Pieters R, Meshinchi S, van den Heuvel-Eibrink MM, Zwaan CM.

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX-gene expression pattern.

Leukemia. 2013 Mar 27

 

Aalbers AM, Calado RT, Young NS, Zwaan CM, Wu C, Kajigaya S, Coenen EA, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Kuijpers TW, Reinhardt D, Trka J, Zimmermann M, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM.

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

Leukemia. 2013 Feb 21.


Bessho F, Takayama N, Fronkova E, Zuna J.

Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blasts.

Int J Hematol. 2013 Feb 19.

 

2012 

Kramarzova K, Boublikova L, Stary J, Trka J.

Evaluation of WT1 expression in bone marrow vs peripheral blood samples of children with acute myeloid leukemia-impact on minimal residual disease detection.

Leukemia. 2012 Oct 10.


Volejnikova J, Mejstrikova E, Dörge P, Meissner B, Zimmermannova O, Svojgr K, Stanulla M, Cario G, Schrappe M, Stary J, Hrusak O, Trka J, Fronkova E.

Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.

Pediatr Blood Cancer. 2012 Sep 19


Mejstríková E, Janda A, Hrusák O, Bucková H, Vlcková M, Hancárová M, Freiberger T, Ravcuková B, Vesely K, Fajkusová L, Kopecková L, Sumerauer D, Kabícková E, Sedivá A, Stary J, Sedlácek Z.

Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.

Pediatrics. 2012 Feb;129(2):e523-8. Epub 2012 Jan 23.


Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Böttcher S, Ritgen M, Almeida J, Lhermitte L, Asnafi V, Mendonça A, de Tute R, Cullen M, Sedek L, Vidriales MB, Pérez JJ, Te Marvelde JG, Mejstrikova E, Hrusak O, Szczepański T, van Dongen JJ, Orfao A.

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Leukemia. 2012 Sep;26(9):1986-2010. doi: 10.1038/leu.2012.122.


Hermanova I, Zaliova MK, Trka J, Starkova J.
Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Exp Hematol. 2012 Apr 25. [Epub ahead of print]


Kramarzova K, Stuchly J, Willasch A, Gruhn B, Schwarz J, Cermak J, Machova-Polakova K, Fuchs O, Stary J, Trka J, Boublikova L.
Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences
Leukemia, 2012 Mar 20. [Epub ahead of print]  

 

Stuchly, J., Kanderova, V., Fiser, K., Cerna, D., Holm, A., Wu, W., Hrusak, O., Lund-Johansen, F., Kalina, T. 
An automated analysis of highly complex flow cytometry-based proteomic data
Cytometry A (2012), Feb; 81(2), 120-129


Svojgr, K., Kalina, T., Kanderova, V., Skopcova, T., Brdicka, T., Zuna, J. 
The adaptor protein NTAL enhances proximal signaling and potentiates corticosteroid-induced apoptosis in T-ALL
Exp Hematol2012 Jan 20. [Epub ahead of print]


Zapotocky, M., Mejstrikova, E., Smetana, K., Stary, J., Trka, J., & Starkova, J. 
Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically
Cancer Lett2012 Jan 17. [Epub ahead of print]


Fiser, K., Sieger, T., Schumich, A., Wood, B., Irving, J., Mejstrikova, E., & Dworzak, M. N. 
Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data
Cytometry A (2012), Jan;81(1):25-34


 

Hoffmann J, Fiser K, Weaver J, Dimmick I, Loeher M, Pircher H, Martin-Ruiz C, Veerasamy M, Keavney B, von Zglinicki T, Spyridopoulos I. 

High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.

PLoS One. 2012;7(10)


Aalbers AM, Calado RT, Young NS, Zwaan CM, Kajigaya S, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Reinhardt D, Trka J, Kuijpers TW, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM.

Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia.

Br J Haematol. 2012 Nov 28

Lutz C, Woll PS, Hall G, Castor A, Dreau H, Cazzaniga G, Zuna J, Jensen C, Clark SA, Biondi A, Mitchell C, Ferry H, Schuh A, Buckle V, Jacobsen SE, Enver T.

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.

Leukemia. 2012 Oct 22. doi: 10.1038/leu.2012.306. [Epub ahead of print] 

 

Creutzig U, van den Heuvel-Eibrink MM, Gibson B, Dworzak MN, Adachi S, de Bont E, Harbott J, Hasle H, Johnston D, Kinoshita A, Lehrnbecher T, Leverger G,Mejstrikova E, Meshinchi S, Pession A, Raimondi SC, Sung L, Stary J, Zwaan CM, Kaspers GJ, Reinhardt D; on behalf of the AML Committee of the International BFM Study Group.

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Blood. 2012 Oct 18;120(16):3187-3205. Epub 2012 Aug 9.


Dekking EH, van der Velden VH, Varro R, Wai H, Böttcher S, Kneba M, Sonneveld E, Koning A, Boeckx N, Van Poecke N, Lucio P, Mendonça A, Sedek L, Szczepański T, Kalina T, Kanderová V, Hoogeveen P, Flores-Montero J, Chillón MC, Orfao A, Almeida J, Evans P, Cullen M, Noordijk AL, Vermeulen PM, de Man MT, Dixon EP, Comans-Bitter WM, van Dongen JJ. 
Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.

Leukemia. 2012 Sep;26(9):1976-85. doi: 10.1038/leu.2012.125. Epub 2012 May 8.


Inthal A, Zeitlhofer P, Zeginigg M, Morak M, Grausenburger R, Fronkova E, Fahrner B, Mann G, Haas OA, Panzer-Grümayer R.

CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia.

Leukemia. 2012 Aug;26(8):1797-803. doi: 10.1038/leu.2012.60. Epub 2012 Mar 5. 

 

Luesink M, Hollink IH, van der Velden VH, Knops RH, Boezeman JB, de Haas V, Trka J, Baruchel A, Reinhardt D, van der Reijden BA, van den Heuvel-Eibrink MM, Zwaan CM, Jansen JH.
High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.

Blood. 2012 Jul 11. [Epub ahead of print]


Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, Al-Jefri A, Beier R, Bomme Ousager L, Ehlert K, Gross-Wieltsch U, Jorch N, Kremens B,Pekrun A, Sparber-Sauer M, Mejstrikova E, Wawer A, Ehl S, zur Stadt U, Janka G.

Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).

Blood. 2012 Jun 21;119(25):6016-24. Epub 2012 Mar 26.


van Dongen JJ, Lhermitte L, Böttcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, Lécrevisse Q, Lucio P, Mejstrikova E, Szczepañski T, Kalina T, de Tute R, Brüggemann M, Sedek L, Cullen M, Langerak AW, Mendonça A, Macintyre E, Martin-Ayuso M, Hrusak O, Vidriales MB, Orfao 

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
Leukemia, 2012 May 3.[Epub ahead of print]


Inthal A, Zeitlhofer P, Zeginigg M, Morak M, Grausenburger R, Fronkova E, Fahrner B, Mann G, Haas OA, Panzer-Grümayer R.
CREBBP HAT domain mutations prevail in relapse cases of high hyperdiploid childhood acute lymphoblastic leukemia.
Leukemia, 2012 Mar 5.[Epub ahead of print]


Majer, F., Vlaskova, H., Krol, L., Kalina, T., Kubanek, M., Stolnaya, L., Dvorakova, L., Elleder, M., & Sikora, J.  
Danon disease: A focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency
Gene, 2012 May 1;498(2):183-95 

 

Bodor, C., Renneville, A., Smith, M., Charazac, A., Iqbal, S., Etancelin, P., Cavenagh, J., Barnett, M. J., Kramarzova, K., Krishnan, B., Matolcsy, A., Preudhomme, C., Fitzgibbon, J., & Owen, C. 
Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival
Haematologica, 2012 Jan 22. [Epub ahead of print]


2011 

Volejnikova, J., Mejstrikova, E., Valova, T., Reznickova, L., Hodonska, L., Mihal, V., Sterba, J., Jabali, Y., Prochazkova, D., Blazek, B., Hak, J., Cerna, Z., Hrusak, O., Stary, J., Trka, J., & Fronkova, E. 
Minimal residual disease in peripheral blood at day 15 identifies subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis
Haematologica (2011), Dec;96(12):1815-21 

Starkova, J., Gadgil, S., Qiu, Y. H., Zhang, N., Hermanova, I., Kornblau, S. M., & Drabkin, H. A. 
Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling
Haematologica (2011), 96(6), 820-828 

Zuna, J., Madzo, J., Krejci, O., Zemanova, Z., Kalinova, M., Muzikova, K., Zapotocky, M., Starkova, J., Hrusak, O., Horak, J., & Trka, J. 
ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia
Blood (2011), 117(1), 368-369; author reply 370-361 

Vaskova, M., Kovac, M., Volna, P., Angelisova, P., Mejstrikova, E., Zuna, J., Brdicka, T., & Hrusak, O. 
High expression of cytoskeletal protein drebrin in TEL/AML1(pos) B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody
Leuk Res (2011), 35(8), 1111-1113 

Zaliova, M., Meyer, C., Cario, G., Vaskova, M., Marschalek, R., Stary, J., Zuna, J., & Trka, J. 
TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases
Pediatr Blood Cancer (2011), 56(2), 217-225 

Zaliova, M., Madzo, J., Cario, G., & Trka, J. 
Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing
Leukemia (2011), Feb;25(2):313-20 

Krol, L., Stuchly, J., Hubacek, P., Keslova, P., Sedlacek, P., Stary, J., Hrusak, O., & Kalina, T. 
Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
Bone Marrow Transplant (2011), 46(8), 1089-1098 

Ellinghaus, E., Stanulla, M., Richter, G., Ellinghaus, D., Te Kronnie, G., Cario, G., Cazzaniga, G., Horstmann, M., Panzer Grumayer, R., Cave, H., Trka, J., Cinek, O., Teigler-Schlegel, A., Elsharawy, A., Hasler, R., Nebel, A., Meissner, B., Bartram, T., Lescai, F., Franceschi, C., Giordan, M., Nurnberg, P., Heinzow, B., Zimmermann, M., Schreiber, S., Schrappe, M., & Franke, A. 
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia
Leukemia (2011), 

Slaastad, H., Wu, W., Goullart, L., Kanderova, V., Tjonnfjord, G., Stuchly, J., Kalina, T., Holm, A., & Lund-Johansen, F. 
Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins
Proteomics (2011), 11(23), 4578-4582 

Hollink, I. H., Feng, Q., Danen-van Oorschot, A. A., Arentsen-Peters, S. T., Verboon, L. J., Zhang, P., de Haas, V., Reinhardt, D., Creutzig, U., Trka, J., Pieters, R., van den Heuvel-Eibrink, M. M., Wang, J., & Zwaan, C. M. 
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model
Leukemia (2011), 

Danen-van Oorschot, A. A., Kuipers, J. E., Arentsen-Peters, S., Schotte, D., de Haas, V., Trka, J., Baruchel, A., Reinhardt, D., Pieters, R., Michel Zwaan, C., & van den Heuvel-Eibrink, M. M. 
Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
Pediatr Blood Cancer (2011), 

Hollink, I. H., van den Heuvel-Eibrink, M. M., Arentsen-Peters, S. T., Pratcorona, M., Abbas, S., Kuipers, J. E., van Galen, J. F., Beverloo, H. B., Sonneveld, E., Kaspers, G. J., Trka, J., Baruchel, A., Zimmermann, M., Creutzig, U., Reinhardt, D., Pieters, R., Valk, P. J., & Zwaan, C. M. 
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Blood (2011), 118(13), 3645-3656 

Stepanek, O., Kalina, T., Draber, P., Skopcova, T., Svojgr, K., Angelisova, P., Horejsi, V., Weiss, A., & Brdicka, T. 
Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148
J Biol Chem (2011), 286(25), 22101-22112 

van Delft, F. W., Horsley, S., Colman, S., Anderson, K., Bateman, C., Kempski, H., Zuna, J., Eckert, C., Saha, V., Kearney, L., Ford, A., & Greaves, M. 
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
Blood (2011), 117(23), 6247-6254 

Hollink, I. H., van den Heuvel-Eibrink, M. M., Arentsen-Peters, S. T., Zimmermann, M., Peeters, J. K., Valk, P. J., Balgobind, B. V., Sonneveld, E., Kaspers, G. J., de Bont, E. S., Trka, J., Baruchel, A., Creutzig, U., Pieters, R., Reinhardt, D., & Zwaan, C. M. 
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
Haematologica (2011), 96(3), 384-392 

Pachlopnik Schmid, J., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F., Kanegane, H., Lopez-Granados, E., Mejstrikova, E., Pellier, I., Galicier, L., Galambrun, C., Barlogis, V., Bordigoni, P., Fourmaintraux, A., Hamidou, M., Dabadie, A., Le Deist, F., Haerynck, F., Ouachee-Chardin, M., Rohrlich, P., Stephan, J. L., Lenoir, C., Rigaud, S., Lambert, N., Milili, M., Schiff, C., Chapel, H., Picard, C., de Saint Basile, G., Blanche, S., Fischer, A., & Latour, S. 
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
Blood (2011), 117(5), 1522-1529 

Balgobind, B. V., Van den Heuvel-Eibrink, M. M., De Menezes, R. X., Reinhardt, D., Hollink, I. H., Arentsen-Peters, S. T., van Wering, E. R., Kaspers, G. J., Cloos, J., de Bont, E. S., Cayuela, J. M., Baruchel, A., Meyer, C., Marschalek, R., Trka, J., Stary, J., Beverloo, H. B., Pieters, R., Zwaan, C. M., & den Boer, M. L. 
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
Haematologica (2011), 96(2), 221-230 

Sediva, A., Polouckova, A., Podrazil, M., Fronkova, E., & Kalina, T. 
Characterization of the B-cell compartment in a patient with Schnitzler syndrome
Scand J Rheumatol (2011), 40(2), 158-160

 

2010

Vlkova, M., Fronkova, E., Kanderova, V., Janda, A., Ruzickova, S., Litzman, J., Sediva, A., & Kalina, T. Characterization of Lymphocyte Subsets in Patients with Common Variable Immunodeficiency Reveals Subsets of Naive Human B Cells Marked by CD24 Expression
J Immunol (2010), 185(11), 6431-6438

Starkova, J., Zamostna, B., Mejstrikova, E., Krejci, R., Drabkin, H. A., & Trka, J. 
HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL
Pediatr Blood Cancer (2010), 55(6), 1072-1082

Zuna, J., Zaliova, M., Muzikova, K., Meyer, C., Lizcova, L., Zemanova, Z., Brezinova, J., Votava, F., Marschalek, R., Stary, J., & Trka, J. 
Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin
Genes Chromosomes Cancer (2010), 49(10), 873-884

Kanderova, V., Hrusak, O., & Kalina, T. 
Aberrantly expressed CEACAM6 is involved in the signaling leading to apoptosis of acute lymphoblastic leukemia cells
Exp Hematol (2010), 38(8), 653-660 e651

Mejstrikova, E., Fronkova, E., Kalina, T., Omelka, M., Batinic, D., Dubravcic, K., Pospisilova, K., Vaskova, M., Luria, D., Cheng, S. H., Ng, M., Leung, Y., Kappelmayer, J., Kiss, F., Izraeli, S., Stark, B., Schrappe, M., Trka, J., Stary, J., & Hrusak, O. 
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry
Pediatr Blood Cancer (2010) Jan;54(1):62-70.

Mejstrikova, E., Volejnikova, J., Fronkova, E., Zdrahalova, K., Kalina, T., Sterba, J., Jabali, Y., Mihal, V., Blazek, B., Cerna, Z., Prochazkova, D., Hak, J., Zemanova, Z., Jarosova, M., Oltova, A., Sedlacek, P., Schwarz, J., Zuna, J., Trka, J., Stary, J., & Hrusak, O. 
Prognosis of children with mixed phenotype acute leukemia treated in accordance with consistent immunophenotypic criteria
Haematologica (2010) Jun;95(6):928-35. Epub 2010 Feb 9.

Dekking, E., van der Velden, V. H., Bottcher, S., Bruggemann, M., Sonneveld, E., Koning-Goedheer, A., Boeckx, N., Lucio, P., Sedek, L., Szczepanski, T., Kalina, T., Kovac, M., Evans, P., Hoogeveen, P. G., Flores-Montero, J., Orfao, A., Comans-Bitter, W. M., Staal, F. J., & van Dongen, J. J.Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay
Best Pract Res Clin Haematol (2010), 23(3), 333-345

Pachlopnik Schmid, J., Canioni, D., Moshous, D., Touzot, F., Mahlaoui, N., Hauck, F., Kanegane, H., Lopez-Granados, E., Mejstrikova, E., Pellier, I., Galicier, L., Galambrun, C., Barlogis, V., Bordigoni, P., Fourmaintraux, A., Hamidou, M., Dabadie, A., Le Deist, F., Haerynck, F., Ouachee-Chardin, M., Rohrlich, P., Stephan, J. L., Lenoir, C., Rigaud, S., Lambert, N., Milili, M., Schiff, C., Chapel, H., Picard, C., de Saint Basile, G., Blanche, S., Fischer, A., & Latour, S. 
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
Blood (2011), 117(5), 1522-1529

Harrison, C. J., Haas, O., Harbott, J., Biondi, A., Stanulla, M., Trka, J., & Izraeli, S. 

Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group
Br J Haematol (2010), 151(2), 132-142

Lizcova, L., Zemanova, Z., Malinova, E., Jarosova, M., Mejstrikova, E., Smisek, P., Pospisilova, D., Stary, J., & Michalova, K. 
A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome
Cancer Genet Cytogenet, (2010) 201(1), 52-56

Lemez, P., Attarbaschi, A., Bene, M. C., Bertrand, Y., Castoldi, G., Forestier, E., Garand, R., Haas, O. A., Kagialis-Girard, S., Ludwig, W. D., Matutes, E., Mejstrikova, E., Pages, M. P., Pickl, W., Porwit, A., Orfao, A., Schabath, R., Stary, J., Strobl, H., Talmant, P., van't Veer, M. B., & Zemanova, Z. 
Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases

Eur J Haematol (2010), 85(4), 300-308

Hollink, I. H., van den Heuvel-Eibrink, M. M., Zimmermann, M., Balgobind, B. V., Arentsen-Peters, S. T., Alders, M., Willasch, A., Kaspers, G. J., Trka, J., Baruchel, A., Creutzig, U., Pieters, R., Reinhardt, D., & Zwaan, C. M. 
No Prognostic Impact of the WT1 Gene Single Nucleotide Polymorphism rs16754 in Pediatric Acute Myeloid Leukemia
J Clin Oncol

Stary, J., Jabali, Y., Trka, J., Hrusak, O., Gajdos, P., Hrstkova, H., Sterba, J., Blazek, B., Hak, J., Prochazkova, D., Cerna, Z., Smisek, P., Sedlacek, P., Vavra, V., Mihal, V., & Hrodek, O. 
Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic
Leukemia (2010), 24(2), 425-428

Lysak, D., Kalina, T., Martinek, J., Pikalova, Z., Vokurkova, D., Jaresova, M., Marinov, I., Ondrejkova, A., Spacek, M., & Stehlikova, O. 
Interlaboratory variability of CD34+ stem cell enumeration. A pilot study to national external quality assessment within the Czech Republic
Int J Lab Hematol (2010), 32(6 Pt 1), e229-236

Gefen, N., Binder, V., Zaliova, M., Linka, Y., Morrow, M., Novosel, A., Edry, L., Hertzberg, L., Shomron, N., Williams, O., Trka, J., Borkhardt, A., & Izraeli, S. 
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
Leukemia (2010), 24(1), 89-96

Balgobind, B. V., Lugthart, S., Hollink, I. H., Arentsen-Peters, S. T., van Wering, E. R., de Graaf, S. S., Reinhardt, D., Creutzig, U., Kaspers, G. J., de Bont, E. S., Stary, J., Trka, J., Zimmermann, M., Beverloo, H. B., Pieters, R., Delwel, R., Zwaan, C. M., & van den Heuvel-Eibrink, M. M. 
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia

Leukemia (2010), 24(5), 942-949

 

2009

Kalina, T., Stuchly, J., Janda, A., Hrusak, O., Ruzickova, S., Sediva, A., Litzman, J., & Vlkova, M. 
Profiling of polychromatic flow cytometry data on B-cells reveals patients' clusters in common variable immunodeficiency
Cytometry A (2009), 75A(11), 902-909

Zuna, J., Prouzova, Z., Kalina, T., Lizcova, L., Zemanova, Z., Muzikova, K., Rahmatova, S., Meijerink, J. P., & Trka, J. 
Backtracking of ALL to cord blood
Leuk Res (2009), 33(8), e107-108

Zuna, J., Burjanivova, T., Mejstrikova, E., Zemanova, Z., Muzikova, K., Meyer, C., Horsley, S. W., Kearney, L., Colman, S., Ptoszkova, H., Marschalek, R., Hrusak, O., Stary, J., Greaves, M., & Trka, J. 
Covert preleukemia driven by MLL gene fusion
Genes Chromosomes Cancer (2009), 48(1), 98-107

Zaliova, M., Fronkova, E., Krejcikova, K., Muzikova, K., Mejstrikova, E., Stary, J., Trka, J., & Zuna, J. 
Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR/ABL-positive ALL: implications for residual disease monitoring
Leukemia (2009), 23(5), 944-951

Svojgr, K., Burjanivova, T., Vaskova, M., Kalina, T., Stary, J., Trka, J., & Zuna, J. 
Adaptor molecules expression in normal lymphopoiesis and in childhood leukemia
Immunol Lett (2009), 122(2), 185-192

Willasch, A. M., Gruhn, B., Coliva, T., Kalinova, M., Schneider, G., Kreyenberg, H., Steinbach, D., Weber, G., Hollink, I. H., Zwaan, C. M., Biondi, A., van der Velden, V. H., Reinhardt, D., Cazzaniga, G., Bader, P., & Trka, J. 
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
Leukemia (2009), 23(8), 1472-1479

Weerkamp, F., Dekking, E., Ng, Y. Y., van der Velden, V. H., Wai, H., Bottcher, S., Bruggemann, M., van der Sluijs, A. J., Koning, A., Boeckx, N., Van Poecke, N., Lucio, P., Mendonca, A., Sedek, L., Szczepanski, T., Kalina, T., Kovac, M., Hoogeveen, P. G., Flores-Montero, J., Orfao, A., Macintyre, E., Lhermitte, L., Chen, R., Brouwer-De Cock, K. A., van der Linden, A., Noordijk, A. L., Comans-Bitter, W. M., Staal, F. J., & van Dongen, J. J. 
Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients
Leukemia (2009), 23(6), 1106-1117

Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., Delabesse, E., de Oliveira, M. P., Cave, H., Clappier, E., van Dongen, J. J., Balgobind, B. V., van den Heuvel-Eibrink, M. M., Beverloo, H. B., Panzer-Grumayer, R., Teigler-Schlegel, A., Harbott, J., Kjeldsen, E., Schnittger, S., Koehl, U., Gruhn, B., Heidenreich, O., Chan, L. C., Yip, S. F., Krzywinski, M., Eckert, C., Moricke, A., Schrappe, M., Alonso, C. N., Schafer, B. W., Krauter, J., Lee, D. A., Zur Stadt, U., Te Kronnie, G., Sutton, R., Izraeli, S., Trakhtenbrot, L., Lo Nigro, L., Tsaur, G., Fechina, L., Szczepanski, T., Strehl, S., Ilencikova, D., Molkentin, M., Burmeister, T., Dingermann, T., Klingebiel, T., & Marschalek, R. 
New insights to the MLL recombinome of acute leukemias
Leukemia (2009), 23(8), 1490-1499

Horvath, R., Budinsky, V., Kayserova, J., Kalina, T., Formankova, R., Stary, J., Bartunkova, J., Sedlacek, P., & Spisek, R. 
Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease
Clin Immunol (2009), 131(1), 60-69

Hollink, I. H., van den Heuvel-Eibrink, M. M., Zimmermann, M., Balgobind, B. V., Arentsen-Peters, S. T., Alders, M., Willasch, A., Kaspers, G. J., Trka, J., Baruchel, A., de Graaf, S. S., Creutzig, U., Pieters, R., Reinhardt, D., & Zwaan, C. M. 
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
Blood (2009), 113(23), 5951-5960

 

2008

Vaskova, M., Fronkova, E., Starkova, J., Kalina, T., Mejstrikova, E., & Hrusak, O. 
CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis
Tissue Antigens (2008), 71(1), 57-66

Smetana, K., Zapotocky, M., Starkova, J., & Trka, J. 
To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A
Eur J Histochem (2008), 52(3), 143-148

Krol, L., Formankova, R., Keslova, P., Vavra, V., Zemanova, Z., Michalova, K., Dobrovolna, M., Moravcova, J., Kobylka, P., Ivaskova, E., Navratilova, J., Stary, J., & Sedlacek, P. 
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid leukemia in the period from 1989 to 2006 in the Czech Republic
Neoplasma (2008), 55(2), 101-106

Fronkova, E., Muzikova, K., Mejstrikova, E., Kovac, M., Formankova, R., Sedlacek, P., Hrusak, O., Stary, J., & Trka, J. 
B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
Bone Marrow Transplant (2008), 42(3), 187-196

Fronkova, E., Mejstrikova, E., Avigad, S., Chik, K. W., Castillo, L., Manor, S., Reznickova, L., Valova, T., Zdrahalova, K., Hrusak, O., Jabali, Y., Schrappe, M., Conter, V., Izraeli, S., Li, C. K., Stark, B., Stary, J., & Trka, J. 
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Leukemia (2008), 22(5), 989-997

Metzler, M., Staege, M. S., Harder, L., Mendelova, D., Zuna, J., Fronkova, E., Meyer, C., Flohr, T., Bednarova, D., Harbott, J., Langer, T., Gesk, S., Trka, J., Siebert, R., Dingermann, T., Marschalek, R., Niemeyer, C., & Rascher, W. 
Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia
Leukemia (2008), 22(9), 1807-1811

Kerst, G., Bergold, N., Gieseke, F., Coustan-Smith, E., Lang, P., Kalinova, M., Handgretinger, R., Trka, J., & Muller, I. 
WT1 protein expression in childhood acute leukemia
Am J Hematol (2008), 83(5), 382-386

Bercovich, D., Ganmore, I., Scott, L. M., Wainreb, G., Birger, Y., Elimelech, A., Shochat, C., Cazzaniga, G., Biondi, A., Basso, G., Cario, G., Schrappe, M., Stanulla, M., Strehl, S., Haas, O. A., Mann, G., Binder, V., Borkhardt, A., Kempski, H., Trka, J., Bielorei, B., Avigad, S., Stark, B., Smith, O., Dastugue, N., Bourquin, J. P., Tal, N. B., Green, A. R., & Izraeli, S. 
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Lancet (2008), 372(9648), 1484-1492

 

2007

Zuna, J., Cave, H., Eckert, C., Szczepanski, T., Meyer, C., Mejstrikova, E., Fronkova, E., Muzikova, K., Clappier, E., Mendelova, D., Boutard, P., Schrauder, A., Sterba, J., Marschalek, R., van Dongen, J. J., Hrusak, O., Stary, J., & Trka, J. 
Childhood secondary ALL after ALL treatment
Leukemia (2007), 21(7), 1431-1435

Starkova, J., Madzo, J., Cario, G., Kalina, T., Ford, A., Zaliova, M., Hrusak, O., & Trka, J. 
The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells
Clin Cancer Res (2007), 13(6), 1726-1735

Sramkova, L., Muzikova, K., Fronkova, E., Krejci, O., Sedlacek, P., Formankova, R., Mejstrikova, E., Stary, J., & Trka, J. 
Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia
Pediatr Blood Cancer (2007), 48(1), 93-100

Smetana, K., Zapotocky, M., Starkova, J., & Trka, J. 
Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro - A cytochemical study
Acta Histochem (2007)

Smetana, K., Kuzelova, K., Zapotocky, M., Starkova, J., Hrkal, Z., & Trka, J. 
Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle
Eur J Histochem (2007), 51(4), 269-274

Janda, A., Sedlacek, P., Mejstrikova, E., Zdrahalova, K., Hrusak, O., Kalina, T., Sieglova, Z., Zizkova, H., Formankova, R., Keslova, P., Hubacek, P., Sediva, A., Bartunkova, J., Dlask, K., & Stary, J. 
Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome
Pediatr Transplant (2007), 11(4), 441-447

Hubacek, P., Hyncicova, K., Muzikova, K., Cinek, O., Zajac, M., & Sedlacek, P. 
Disappearance of pre-existing high HHV-6 DNA load in blood after allogeneic SCT
Bone Marrow Transplant (2007), 40(8), 805-806

van der Velden, V. H., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E. R., Flohr, T., Sutton, R., Cave, H., Madsen, H. O., Cayuela, J. M., Trka, J., Eckert, C., Foroni, L., Zur Stadt, U., Beldjord, K., Raff, T., van der Schoot, C. E., & van Dongen, J. J. 
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
Leukemia (2007), 21(4), 604-611

Hagedorn, N., Acquaviva, C., Fronkova, E., von Stackelberg, A., Barth, A., zur Stadt, U., Schrauder, A., Trka, J., Gaspar, N., Seeger, K., Henze, G., Cave, H., & Eckert, C. 
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group
Blood (2007), 110(12), 4022-4029

 

2006

Vaskova, M., Mejstrikova, E., Kalina, T., Trka, J., Stary, J., & Hrusak, O. 
CD27 expression in malignant and normal human B precursors: a confirmed phenomenon. Reply to Nilsson and colleagues
Exp Hematol (2006), 34(5), 573; author reply 574

Sedlacek, P., Formankova, R., Keslova, P., Sramkova, L., Hubacek, P., Krol, L., Kulich, M., & Stary, J. 
Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin
Bone Marrow Transplant (2006), 38(11), 745-750

Burjanivova, T., Madzo, J., Muzikova, K., Meyer, C., Schneider, B., Votava, F., Marschalek, R., Stary, J., Trka, J., & Zuna, J. 
Prenatal origin of childhood AML occurs less frequently than in childhood ALL
BMC Cancer (2006), 6, 100

Boublikova, L., Kalinova, M., Ryan, J., Quinn, F., O'Marcaigh, A., Smith, O., Browne, P., Stary, J., McCann, S. R., Trka, J., & Lawler, M. 
Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring
Leukemia (2006), 20(2), 254-263

Wunderlich, M., Krejci, O., Wei, J., & Mulloy, J. C. 
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Blood (2006), 108(5), 1690-1697

Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M. W., van Dongen, J. J., den Boer, M. L., Pieters, R., Ennas, M. G., Angelucci, E., Koehl, U., Greil, J., Griesinger, F., Zur Stadt, U., Eckert, C., Szczepanski, T., Niggli, F. K., Schafer, B. W., Kempski, H., Brady, H. J., Zuna, J., Trka, J., Nigro, L. L., Biondi, A., Delabesse, E., Macintyre, E., Stanulla, M., Schrappe, M., Haas, O. A., Burmeister, T., Dingermann, T., Klingebiel, T., & Marschalek, R. 
The MLL recombinome of acute leukemias
Leukemia (2006), 20(5), 777-784

Langebrake, C., Creutzig, U., Dworzak, M., Hrusak, O., Mejstrikova, E., Griesinger, F., Zimmermann, M., & Reinhardt, D. 
Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group
J Clin Oncol (2006), 24(22), 3686-3692

 

2005 a dříve

Zuna, J., Krejci, O., Madzo, J., Fronkova, E., Sramkova, L., Hrusak, O., Kalina, T., Vaskova, M., Stary, J., & Trka, J. 
TEL/AML1 and immunoreceptor gene rearrangements-which comes first?
Leuk Res (2005), 29(6), 633-639

Vaskova, M., Mejstrikova, E., Kalina, T., Martinkova, P., Omelka, M., Trka, J., Stary, J., & Hrusak, O. 
Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia
Leukemia (2005), 19(5), 876-878

Mejstrikova, E., Kalina, T., Trka, J., Stary, J., & Hrusak, O. 
Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy
Leukemia (2005), 19(6), 1092-1094

Kalina, T., Vaskova, M., Mejstrikova, E., Madzo, J., Trka, J., Stary, J., & Hrusak, O.
Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens
BMC Cancer (2005), 5(1), 38

Kalina, T., Lu, H., Zhao, Z., Blewett, E., Dittmer, D. P., Randolph-Habecker, J., Maloney, D. G., Andrews, R. G., Kiem, H. P., & Storek, J. 
De novo generation of CD4 T cells against viruses present in the host during immune reconstitution
Blood (2005), 105(6), 2410-2414

Fronkova, E., Madzo, J., Zuna, J., Reznickova, L., Muzikova, K., Hrusak, O., Stary, J., & Trka, J. 
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL
Leukemia (2005), 19(7), 1296-1297

Fronkova, E., Krejci, O., Kalina, T., Horvath, O., Trka, J., & Hrusak, O. 
Lymphoid differentiation pathways can be traced by TCR delta rearrangements
J Immunol (2005), 175(4), 2495-2500

Sediva, A., Bartunkova, J., Zachova, R., Polouckova, A., Hrusak, O., Janda, A., Kocarek, E., Novotna, D., Novotna, K., & Klein, T. 
Early development of immunity in diGeorge syndrome
Med Sci Monit (2005), 11(4), CR182-187

Mulloy, J. C., Jankovic, V., Wunderlich, M., Delwel, R., Cammenga, J., Krejci, O., Zhao, H., Valk, P. J., Lowenberg, B., & Nimer, S. D. 
AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34+ cells, allowing nerve growth factor-induced expansion
Proc Natl Acad Sci U S A (2005), 102(11), 4016-4021

Lu, H., Zhao, Z., Kalina, T., Gillespy, T., 3rd, Liggitt, D., Andrews, R. G., Maloney, D. G., Kiem, H. P., & Storek, J. 
Interleukin-7 improves reconstitution of antiviral CD4 T cells
Clin Immunol (2005), 114(1), 30-41

Zuna, J., Ford, A. M., Peham, M., Patel, N., Saha, V., Eckert, C., Kochling, J., Panzer-Grumayer, R., Trka, J., & Greaves, M. 
TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia
Clin Cancer Res (2004), 10(16), 5355-5360

Krejci, O., Starkova, J., Otova, B., Madzo, J., Kalinova, M., Hrusak, O., & Trka, J. 
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells
Leukemia (2004), 18(3), 434-441

Storek, J., Zhao, Z., Lin, E., Berger, T., McSweeney, P. A., Nash, R. A., Akatsuka, Y., Metcalf, M. D., Lu, H., Kalina, T., Reindl, M., Storb, R., Hansen, J. A., Sullivan, K. M., Kraft, G. H., Furst, D. E., & Maloney, D. G. 
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)
Clin Immunol (2004), 113(3), 285-298

Kracht, T., Schrappe, M., Strehl, S., Reiter, A., Elsner, H. A., Trka, J., Cario, G., Viehmann, S., Harbott, J., Borkhardt, A., Metzler, M., Langer, T., Repp, R., Marschalek, R., Welte, K., Haas, O. A., & Stanulla, M. 
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms
Haematologica (2004), 89(12), 1492-1497

Zuna, J., Muzikova, K., Ford, A. M., Maia, A. T., Krejci, O., Tousovska, K., Oravkinova, I., Greaves, M., & Trka, J. 
Pre-natal, clonal origin of acute lymphoblastic leukaemia in triplets
Leuk Lymphoma (2003), 44(12), 2099-2102

Madzo, J., Zuna, J., Muzikova, K., Kalinova, M., Krejci, O., Hrusak, O., Otova, B., Stary, J., & Trka, J. 
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study
Cancer (2003), 97(1), 105-113

Krejci, O., van der Velden, V. H., Bader, P., Kreyenberg, H., Goulden, N., Hancock, J., Schilham, M. W., Lankester, A., Revesz, T., Klingebiel, T., & van Dongen, J. J. 
Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group
Bone Marrow Transplant (2003), 32(8), 849-851

Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O. A., & Izraeli, S. 
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21
Blood (2003), 102(3), 981-986

Goulden, N., Bader, P., Van Der Velden, V., Moppett, J., Schilham, M., Masden, H. O., Krejci, O., Kreyenberg, H., Lankester, A., Revesz, T., Klingebiel, T., & Van Dongen, J. 
Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia
Br J Haematol (2003), 122(1), 24-29

Zuna, J., Muzikova, K., Madzo, J., Krejci, O., & Trka, J. 
Temperature non-homogeneity in rapid airflow-based cycler significantly affects real-time PCR
Biotechniques (2002), 33(3), 508, 510, 512

Zuna, J., Muzikova, K., Hrusak, O., Stary, J., & Trka, J. 
Significance of real-time quantitative PCR detection of p16 gene deletions in childhood acute lymphoblastic leukemia
Haematologica (2002), 87(6), 668-669

Trka, J., Kalinova, M., Hrusak, O., Zuna, J., Krejci, O., Madzo, J., Sedlacek, P., Vavra, V., Michalova, K., Jarosova, M., & Stary, J. 
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry
Leukemia (2002), 16(7), 1381-1389

Stary, J., Gajdos, P., Hrstkova, H., Blazek, B., Slavik, Z., Mihal, V., Zahalka, F., Jabali, Y., Vavra, V., Kopecna, L., Mydlil, J., & Trka, J. 
Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology
Med Pediatr Oncol (2002), 39(2), 125-127

Hrusak, O., Trka, J., Zuna, J., Polouckova, A., Kalina, T., & Stary, J. 
Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years
Leukemia (2002), 16(4), 720-725

Hrusak, O., & Porwit-MacDonald, A. 
Antigen expression patterns reflecting genotype of acute leukemias
Leukemia (2002), 16(7), 1233-1258

Reinhardt, D., Langebrake, C., Creutzig, U., Vormoor, J., Brune, C., Thorwesten, M., Ingiliz, P., Hrusak, O., Dworzak, M., & Griesinger, F. 
[Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study]
Klin Padiatr (2002), 214(4), 179-187

Jarosova, M., Holzerova, M., Mihal, V., Blatny, J., Lakoma, I., Trka, J., Pikalova, Z., Hrusak, O., & Indrak, K. 
Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene
Leukemia (2002), 16(9), 1873-1875

Seeger, K., Viehmann, S., Buchwald, D., Harbott, J., Schrappe, M., Stary, J., Henze, G., & Trka, J. 
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL
Leukemia (2001), 15(2), 280-282

Sedlacek, P., Trka, J., Zuna, J., Hrusak, O., Honzatkova-Krskova, L., & Stary, J. 
Monitoring of minimal residual disease and mixed chimerism in a case of high-risk TEL/AML1+ acute lymphoblastic leukemia pre- and post-bone marrow transplantation. Czech Pediatric Haematology Working Group
Haematologica (2000), 85(10), 1100-1102

Myers, R. S., Ball, K. K., Kalina, T. D., Roth, D. L., & Goode, K. T. 
Relation of useful field of view and other screening tests to on-road driving performance
Percept Mot Skills (2000), 91(1), 279-290

Zuna, J., Hrusak, O., Kalinova, M., Muzikova, K., Stary, J., & Trka, J. 
TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group
Leukemia (1999), 13(1), 22-24

Zuna, J., Hrusak, O., Kalinova, M., Muzikova, K., Stary, J., & Trka, J. 
Significantly lower relapse rate for TEL/AML1-positive ALL
Leukemia (1999), 13(10), 1633

Trka, J., Zuna, J., Hrusak, O., Michalova, K., Muzikova, K., Kalinova, M., Horak, J., & Stary, J. 
No evidence for MLL/AF4 expression in normal cord blood samples
Blood (1999), 93(3), 1106-1107; author reply 1108-1110

Hrusak, O., Trka, J., Zuna, J., Bartunkova, J., & Stary, J. 
Are we ready to curtail testing for TEL/AML1 fusion? Pediatric Hematology Working Group in the Czech Republic
Leukemia (1999), 13(6), 981-983

Trka, J., Zuna, J., Hrusak, O., Kalinova, M., Muzikova, K., Lauschman, H., & Stary, J. 
Impact of TEL/AML1-positive patients on age distribution of childhood acute lymphoblastic leukemia in Czech Republic. Pediatric Hematology Working Group in Czech Republic
Leukemia (1998), 12(6), 996-997

Hrusak, O., Trka, J., Zuna, J., Houskova, J., Bartunkova, J., & Stary, J. 
Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic
Leukemia (1998), 12(7), 1064-1070

Eckschlager, T., Pilat, D., Kodet, R., Dahbiova, R., Stankova, J., Jasinska, J., & Hrusak, O. 
DNA ploidy in neuroblastoma
Neoplasma (1996), 43(1), 23-26

Trka, J., Divoky, V., & Lion, T. 
Prevention of product carry-over by single tube two-round (ST-2R) PCR: application to BCR-ABL analysis in chronic myelogenous leukemia
Nucleic Acids Res (1995), 23(22), 4736-4737

Eckschlager, T., Pilat, D., Kodet, R., Stary, J., Jasinska, J., & Hrusak, O. 
[DNA cytometry analysis in childhood tumors]
Cas Lek Cesk (1995), 134(10), 302-305